<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fibrillin-1 is a modular <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> and a major component of the 10-12 nm microfibrils of the extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in the fibrillin-1 (FBN 1) gene result in the <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> the <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) and related disorders </plain></SENT>
<SENT sid="2" pm="."><plain>The calcium binding EGF-like (cbEGF) domain is the predominant structural motif of the protein and &gt;70% of mutations leading to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> disrupt this domain </plain></SENT>
<SENT sid="3" pm="."><plain>A missense mutation which changes a proline to alanine (P1148A) in cbEGF domain 13 has been associated with a number of fibrillin disorders including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and <z:e sem="disease" ids="C1321551" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Shprintzen-Goldberg syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>However, it has also been described as a polymorphism </plain></SENT>
<SENT sid="5" pm="."><plain>In this study comparative NMR analyses on <z:mp ids='MP_0002169'>wild-type</z:mp> and mutant forms of covalently-linked fibrillin cbEGF domain pairs have been performed to investigate the structural consequences of this substitution </plain></SENT>
<SENT sid="6" pm="."><plain>A comparison of the two-dimensional NOESY spectra of the <z:mp ids='MP_0002169'>wild-type</z:mp> and mutant forms of cbEGF domains 12 &amp; 13 and cbEGF domains 13 &amp; 14 indicated that the proline to alanine amino acid change does not introduce a significant structural defect into cbEGF domain 13 or the adjacent domains and most likely represents a polymorphism </plain></SENT>
<SENT sid="7" pm="."><plain>These results demonstrate how, in the case of a protein with a well defined domain organisation such as fibrillin-1, comparative NMR analyses can be used to substantiate genetic evidence for the polymorphic status of an amino acid </plain></SENT>
</text></document>